401 related articles for article (PubMed ID: 17080199)
1. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.
Tesseur I; Zou K; Esposito L; Bard F; Berber E; Can JV; Lin AH; Crews L; Tremblay P; Mathews P; Mucke L; Masliah E; Wyss-Coray T
J Clin Invest; 2006 Nov; 116(11):3060-9. PubMed ID: 17080199
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of TGF-beta signaling in Alzheimer's disease.
Das P; Golde T
J Clin Invest; 2006 Nov; 116(11):2855-7. PubMed ID: 17080189
[TBL] [Abstract][Full Text] [Related]
3. GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease.
Audoy-Rémus J; Bozoyan L; Dumas A; Filali M; Lecours C; Lacroix S; Rivest S; Tremblay ME; Vallières L
Brain Behav Immun; 2015 May; 46():112-20. PubMed ID: 25637481
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
Wyss-Coray T
J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
7. The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration.
Sagy-Bross C; Kasianov K; Solomonov Y; Braiman A; Friedman A; Hadad N; Levy R
J Neurochem; 2015 Mar; 132(5):559-71. PubMed ID: 25533654
[TBL] [Abstract][Full Text] [Related]
8. Smad3 deficiency increases cortical and hippocampal neuronal loss following traumatic brain injury.
Villapol S; Wang Y; Adams M; Symes AJ
Exp Neurol; 2013 Dec; 250():353-65. PubMed ID: 24120438
[TBL] [Abstract][Full Text] [Related]
9. Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model.
Sesele K; Thanopoulou K; Paouri E; Tsefou E; Klinakis A; Georgopoulos S
Aging Cell; 2013 Dec; 12(6):1032-40. PubMed ID: 23826707
[TBL] [Abstract][Full Text] [Related]
10. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.
Casas C; Sergeant N; Itier JM; Blanchard V; Wirths O; van der Kolk N; Vingtdeux V; van de Steeg E; Ret G; Canton T; Drobecq H; Clark A; Bonici B; Delacourte A; Benavides J; Schmitz C; Tremp G; Bayer TA; Benoit P; Pradier L
Am J Pathol; 2004 Oct; 165(4):1289-300. PubMed ID: 15466394
[TBL] [Abstract][Full Text] [Related]
11. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
[TBL] [Abstract][Full Text] [Related]
12. In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.
Stoppelkamp S; Bell HS; Palacios-Filardo J; Shewan DA; Riedel G; Platt B
Exp Neurol; 2011 Jun; 229(2):226-37. PubMed ID: 21295028
[TBL] [Abstract][Full Text] [Related]
13. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.
Baglietto-Vargas D; Chen Y; Suh D; Ager RR; Rodriguez-Ortiz CJ; Medeiros R; Myczek K; Green KN; Baram TZ; LaFerla FM
J Neurochem; 2015 Sep; 134(5):915-26. PubMed ID: 26077803
[TBL] [Abstract][Full Text] [Related]
14. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC
Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652
[TBL] [Abstract][Full Text] [Related]
15. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.
Wyss-Coray T; Yan F; Lin AH; Lambris JD; Alexander JJ; Quigg RJ; Masliah E
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10837-42. PubMed ID: 12119423
[TBL] [Abstract][Full Text] [Related]
16. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
18. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease.
Liu Y; Yoo MJ; Savonenko A; Stirling W; Price DL; Borchelt DR; Mamounas L; Lyons WE; Blue ME; Lee MK
J Neurosci; 2008 Dec; 28(51):13805-14. PubMed ID: 19091971
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis.
Salins P; He Y; Olson K; Glazner G; Kashour T; Amara F
Neurosci Lett; 2008 Jan; 430(1):81-6. PubMed ID: 18063474
[TBL] [Abstract][Full Text] [Related]
20. Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's.
Wyss-Coray T
Curr Alzheimer Res; 2006 Jul; 3(3):191-5. PubMed ID: 16842094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
